Genetic Testing - Prohibitions on Disability, Life, and Long-Term Care Insurance (Genetic Testing Protection Act of 2024)
If enacted, HB 982 would alter existing Kentucky insurance laws related to the handling of genetic information. With the explicit protections against discrimination based on genetic testing, the bill could potentially influence how insurers assess risk and eligibility for coverage. By disallowing adverse actions based on genetic data, the law aims to reassure individuals that their genetic information will not adversely affect their insurance options, encouraging more people to consider genetic testing for health monitoring without fear of repercussion.
House Bill 982, entitled the Genetic Testing Protection Act of 2024, seeks to safeguard individuals from insurance discrimination based on genetic testing. The bill specifically prohibits insurance carriers from denying or limiting coverage due to genetic test results or the applicant's decision to undergo genetic testing. The provisions apply to various insurance types, including life insurance, long-term care insurance, and disability insurance, aiming to create a fairer insurance landscape where genetic predispositions do not preclude access to necessary coverage. This initiative reflects a significant shift in how genetic information is treated by insurance providers, promoting a more inclusive approach toward policyholders.
Notably, the legislation may encounter opposition from insurance companies who might argue that such prohibitions could complicate risk assessment processes, potentially leading to higher premiums or reduced benefits for other policyholders. This contention underscores a balancing act between protecting individual rights to genetic privacy and the commercial interests of insurance providers who assess actuarial risks. Ongoing discussions will likely focus on determining the best methods to integrate these protections into existing insurance frameworks while maintaining the integrity of the insurance market.